STRG 10-K & 10-Q changes, risk factors and insider trading

Our operating expenses for the year ended January 31, 20252026 were $84,147$76,623 compared to $112,821$84,147 for the year ended January 31, 2024.2025. The decrease in operating expenses was mainly due to ana decrease in depreciation on plant and equipment and professional fees includes audit and accounting fees.

Our other expenses for the year ended January 31, 20252026 were $6,801$4,404 compared to $93,355$6,801 for the year ended January 31, 2024.2025. During the year ended January 31, 2024,2026 and 2025, the Company recognized foreign exchange gain of $5,000 and incurred impairmentforeign exchange loss on software of $69,841$1,072, and impairment loss on goodwill of $26,319.respectively.

Our total current assets as of January 31, 20252026 were $4$140 as compared to total current assets of $161$4 as of January 31, 20242025 due to aan decreaseincrease in cash.cash and accounts receivable.

During the year ended January 31, 2024,2025, the net cash used in operating activities was attributed to net loss of $202,345$90,712 reduced by depreciation of $12,386,$580, impairmentreduced loss on software of $69,841, impairment loss on goodwill of $26,319,by changes in operating assets and liabilities of $31,055, and increased by accounts payable written off of $2,982.$31,189.

The following summary of our results of operations should be read in conjunction with our financial statements for the three months and nine months ended OctoberApril 31,30, 20252026 and 2024,2025, which are included herein.

Three months ended OctoberApril 31,30, 20252026 compared to three months ended OctoberApril 31,30, 20242025

The Company incurred net loss of $18,812$14,784 for the three months ended OctoberApril 31,30, 20252026 compared to a net loss of $16,847$12,794 for the three months ended OctoberApril 31,30, 2024.2025. The increase in net loss during the three months ended OctoberApril 31,30, 20252026 was mainly due to a increase in other expenses.

Operating expenses for the three months ended OctoberApril 31,30, 20252026 were $15,769$11,514 compared to $15,374$14,089 for the three months ended OctoberApril 31,30, 2024.2025.

Other expenses for the three months ended OctoberApril 31,30, 20252026 were $3,043$3,270 compared to $1,573other income of $1,295 for the three months ended OctoberApril 31,30, 2024.2025. The increase in other expense was due to an increase in interest expense incurred from convertible note.

Our total current assets as of OctoberApril 31,30, 20252026 were $9$14 as compared to total current assets of $4$140 as of January 31, 20252026 due to ana increasedecrease in cash.

Our total current liabilities as of OctoberApril 31,30, 20252026 were $396,982$449,055 as compared to total current liabilities of $338,626$436,776 as of January 31, 2025.2026. The increase was primarily due to an increase in convertible notes, amount due to related parties and accrued interest.

Our working capital deficit at OctoberApril 31,30, 20252026 was $396,973$449,041 as compared to working capital deficit of $338,622$436,636 as of January 31, 2025.2026. The increase in working capital deficiency was mainly attributed to an increase in convertible notes, amount due to related parties and accrued interest.

Net cash used in operating activities was $33,777$782 for the ninethree months ended OctoberApril 31,30, 20252026 compared with net cash used in operating activities of $47,771$14,624 during the ninethree months ended OctoberApril 31,30, 2024.2025.

During the ninethree months ended OctoberApril 31,30, 2025,2026, the net cash used in operating activities was attributed to net loss of $49,753$14,784 reduced by depreciation of $458$153 and net changes in operating assets and liabilities of $15,518.$13,849.

During the ninethree months ended OctoberApril 31,30, 2024,2025, the net cash used in operating activities was attributed to net loss of $56,678$12,794 reduced by depreciation of $437$146 and increased by net changes in operating assets and liabilities of $8,470.$1,976.

We did not have any investing activities during the ninethree months ended OctoberApril 31,30, 20252026 and 2024.2025.

During the ninethree months ended OctoberApril 31,30, 20252026 and 2024,2025, net cash from financing activities was $36,000$0 and $48,226,$17,950, respectively. During the ninethree months ended OctoberApril 31,30, 2025, we received proceeds from issuance of convertible note to a non-affiliate of $34,350$17,300 and proceeds from related partiesparty of $1,650. During the nine months ended October 31, 2024, we received proceeds from issuance of convertible note to a non-affiliate of $46,076 and proceeds from related parties of $2,150.$650.

As reflected in the accompanying consolidated financial statements, the Company’s current liabilities exceeded its current assets by $396,973,$449,041, has an accumulated deficit of $390,746$434,575 and shareholders’ deficit of $395,864$448,203 as of OctoberApril 31,30, 2025.2026. For the ninethree months ended OctoberApril 31,30, 2025,2026, the Company suffered a net loss of $49,753$14,784 and negative operating cash flow of $33,777.$782. These factors among others raise substantial doubt about our ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent on the financial support from its major shareholder and its ability to raise additional capital and implement its business plan. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.